pyrazinamide has been researched along with Hepatocellular Carcinoma in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| UEMURA, R | 1 |
| Rabina, EV | 1 |
| Semichastnova, AG | 1 |
| Golubiatnikova, GA | 1 |
2 other studies available for pyrazinamide and Hepatocellular Carcinoma
| Article | Year |
|---|---|
BACTERIOSTATIC CHEMOTHERAPEUTIC AGENTS AND THE GROWTH OF MALIGNANT TUMOR.
Topics: Adenoma; Aminosalicylic Acid; Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Antineoplastic A | 1964 |
[Agranulocytosis and toxic hepatic dystrophy during treatment with tuberculostatic drugs].
Topics: Aged; Agranulocytosis; Antitubercular Agents; Carcinoma, Hepatocellular; Chemical and Drug Induced L | 1972 |